โรงพยาบาลศรีนครินทร์ เป็นโรงพยาบาลมหาวิทยาลัยระดับตติยภูมิขั้นสูงแห่งแรกในภาคตะวันออกเฉียงเหนือและเป็นโรงเรียนแพทย์สังกัดคณะแพทยศาสตร์ มหาวิทยาลัยขอนแก่น

During the past decade, Srinagarind Hospital conducted 43 clinical trials. In the 10-year time frame, 43 clinical trials started and 13 clinical trials were completed, i.e. on average, 30.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 8 clinical trials were completed. i.e. 38.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Srinagarind Hospital" #1 sponsor was "Khon Kaen University" with 18 trials, followed by "Janssen Research & Development, LLC" with 5 trials sponsored, "Allergan" with 4 trials sponsored, "Boehringer Ingelheim" with 4 trials sponsored and "The HIV Netherlands Australia Thailand Research Collaboration" with 4 trials sponsored. Other sponsors include 36 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Srinagarind Hospital" #1 collaborator was "Srinagarind Hospital, Khon Kaen University" with 5 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 4 trials as a collaborator, "General Drugs House Co.,LTD." with 2 trials as a collaborator, "Gilead Sciences" with 2 trials as a collaborator and "Medical Research Council" with 2 trials as a collaborator. Other collaborators include 74 different institutions and companies that were collaborators in the rest 79 trials.

According to Clinical.Site data, the most researched conditions in "Srinagarind Hospital" are "Cerebral Palsy" (4 trials), "Muscle Spasticity" (4 trials), "Pediatrics" (4 trials), "Chronic Hepatitis" (3 trials) and "HIV Infections" (3 trials). Many other conditions were trialed in "Srinagarind Hospital" in a lesser frequency.

Most popular intervention types in "Srinagarind Hospital" are "Drug" (59 trials), "Biological" (7 trials), "Device" (5 trials), "Other" (4 trials) and "Procedure" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Cisplatin" (5 trials), "Gemcitabine" (3 trials), "Pembrolizumab" (3 trials) and "Adefovir" (2 trials). Other intervention names were less common.

The vast majority of trials in "Srinagarind Hospital" are 74 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Srinagarind Hospital". 1 are not yet recruiting, 12 are recruiting, 12 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Srinagarind Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Srinagarind Hospital, 3 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 9 trials that are defined as “Not Applicable".